BE709019A - - Google Patents
Info
- Publication number
- BE709019A BE709019A BE709019DA BE709019A BE 709019 A BE709019 A BE 709019A BE 709019D A BE709019D A BE 709019DA BE 709019 A BE709019 A BE 709019A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60737867A | 1967-01-05 | 1967-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE709019A true BE709019A (de) | 1968-07-05 |
Family
ID=24432009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE709019D BE709019A (de) | 1967-01-05 | 1968-01-05 |
Country Status (11)
| Country | Link |
|---|---|
| AT (1) | AT276626B (de) |
| BE (1) | BE709019A (de) |
| CH (1) | CH487181A (de) |
| DE (1) | DE1670301C3 (de) |
| DK (1) | DK126595B (de) |
| FR (2) | FR1580837A (de) |
| GB (1) | GB1213571A (de) |
| IL (1) | IL29235A (de) |
| NL (1) | NL6800176A (de) |
| NO (1) | NO140269C (de) |
| SE (1) | SE349564B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE758764A (fr) * | 1969-11-13 | 1971-05-10 | Bristol Myers Co | Procede de preparation d'agents antibacteriens |
| US3631027A (en) * | 1970-03-27 | 1971-12-28 | Bristol Myers Co | Cephalosporanic acids |
| CH648317A5 (de) | 1977-06-10 | 1985-03-15 | Yamanouchi Pharma Co Ltd | 7alpha-methoxy-7betha-(1,3-dithietan-2- carboxamido)cephalosporansaeurederivate und verfahren zu ihrer herstellung. |
| JPS5854157B2 (ja) * | 1977-06-10 | 1983-12-02 | 山之内製薬株式会社 | セフアロスポリン化合物の新規誘導体ならびにその製造方法 |
| IT1141406B (it) * | 1980-04-01 | 1986-10-01 | Dob Far Spa | Sali della cefapirina con aminoacidi |
| GB2122603A (en) * | 1982-06-25 | 1984-01-18 | Lark Spa | 7-Ä???-(substituted-thio)-acylamidoÜ-cephalosporanic acids |
| US6369049B1 (en) | 1998-04-30 | 2002-04-09 | Eli Lilly And Company | Treatment of mastitis |
-
1967
- 1967-12-28 IL IL2923567A patent/IL29235A/xx unknown
-
1968
- 1968-01-03 DK DK1368A patent/DK126595B/da not_active IP Right Cessation
- 1968-01-03 DE DE19681670301 patent/DE1670301C3/de not_active Expired
- 1968-01-04 NO NO3568A patent/NO140269C/no unknown
- 1968-01-05 CH CH15068A patent/CH487181A/de not_active IP Right Cessation
- 1968-01-05 AT AT13268A patent/AT276626B/de active
- 1968-01-05 BE BE709019D patent/BE709019A/xx not_active IP Right Cessation
- 1968-01-05 SE SE14068A patent/SE349564B/xx unknown
- 1968-01-05 FR FR1580837D patent/FR1580837A/fr not_active Expired
- 1968-01-05 NL NL6800176A patent/NL6800176A/xx unknown
- 1968-01-05 GB GB871/68A patent/GB1213571A/en not_active Expired
- 1968-02-02 FR FR138533A patent/FR8381M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1670301A1 (de) | 1972-02-24 |
| DE1670301B2 (de) | 1975-05-07 |
| SE349564B (de) | 1972-10-02 |
| DE1670301C3 (de) | 1975-12-18 |
| AT276626B (de) | 1969-11-25 |
| CH487181A (de) | 1970-03-15 |
| NO140269B (no) | 1979-04-23 |
| IL29235A (en) | 1971-10-20 |
| FR8381M (de) | 1971-03-01 |
| FR1580837A (de) | 1969-09-12 |
| GB1213571A (en) | 1970-11-25 |
| NO140269C (no) | 1979-08-01 |
| DK126595B (da) | 1973-07-30 |
| NL6800176A (de) | 1968-07-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: BRISTOL-MYERS CY Effective date: 19880105 |